Send to

Choose Destination
Biochemistry. 1991 Oct 15;30(41):9922-31.

Molecular structure of a DNA decamber containing an anticancer nucleoside arabinosylcytosine: conformational perturbation by arabinosylcytosine in B-DNA.

Author information

Department of Physiology and Biophysics, University of Illinois, Urbana-Champaign 61801.


Arabinosylcytosine (araC) is an important anticancer drug that has been shown to be misincorporated into DNA double helix. The incorporation of araC into DNA may have significant conformational consequences that could affect the function of DNA. In this paper, we present the high-resolution 3D structure of an araC-containing decamer d[CCAGGC(araC)TGG], as determined by X-ray diffraction analysis, and assess the possible DNA structural perturbation induced by araC. The modified decamer was crystallized in the monoclinic C2 (a = 31.97 A, b = 25.56 A, c = 34.62 A and beta = 114.50 degrees) space group, the same as that from d(CCAGGCCTGG) [Heinemann, U., & Alings, C. (1989) J. Mol. Biol. 210, 369]. The structure of the araC-containing decamer was solved by the molecular replacement method and refined by the constrained least-squares refinement procedure to obtain a final R factor of 0.187 using 2349 [greater than 2.0 sigma(F)] observed reflections to a resolution of 1.6 A. The overall conformation resembles that of the canonical decamer DNA structure, but with significant differences in regions close to the araC site. The O2' hydroxyl groups of the araC residues lie in the major groove of the helix, and they are in close contact with the C5 methyl and C6 H6 atoms of the thymine on the 3'-side. This creates a higher buckle in the araC7-G14 base pair (14 degrees), as compared to that found in the canonical decamer (9 degrees). This may slightly destabilize B-DNA. No direct intramolecular hydrogen bond is formed, in contrast to the situation when araC is incorporated into Z-DNA.(ABSTRACT TRUNCATED AT 250 WORDS).

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center